Trinity Biotech TRIB
NASDAQ TRIB
$7.51 -0.25 (-3.22%)
As of: Oct 22, 2026 · 3:45 PM EDT

Trinity Biotech (TRIB) Current Deferred Tax Assets (2016)

Updated

Trinity Biotech (TRIB) reported Current Deferred Tax Assets of $13.34 million for the quarter ended Dec 31, 2016.

Analysis

Trinity Biotech (TRIB) Current Deferred Tax Assets (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn
10 Trinity Biotech 4.88 Mn -17.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 13.34 Mn
API Access

Trinity Biotech Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=TRIB&period=max&api_key=YOUR_API_KEY